anti-egfr antibody-drug conjugate cpo301 vs tevimbra
| anti-egfr antibody-drug conjugate cpo301 | tevimbra | |
|---|---|---|
| Developers | 0 | 1 |
| Clinical trials | 0 | 0 |
| FDA decisions | 0 | 0 |
| Generic name | Anti-EGFR Antibody-drug Conjugate CPO301 | tislelizumab |
| anti-egfr antibody-drug conjugate cpo301 | tevimbra | |
|---|---|---|
| Developers | 0 | 1 |
| Clinical trials | 0 | 0 |
| FDA decisions | 0 | 0 |
| Generic name | Anti-EGFR Antibody-drug Conjugate CPO301 | tislelizumab |